Featured Research

from universities, journals, and other organizations

Potential of simple injection on patients with head injury

Date:
July 2, 2011
Source:
London School of Hygiene & Tropical Medicine
Summary:
New research has suggested that tranexamic acid has the potential to prevent people dying from head injuries. It is a cheap, off-patent drug with the potential to help people suffering from brain trauma.

New research has suggested that tranexamic acid has the potential to prevent people dying from head injuries.

The CRASH-2 Intracranial Bleeding Study highlighting the potential of the cheap, off-patent drug to help people suffering from brain trauma is published online by the British Medical Journal.

According to the collaborators -- led by the London School of Hygiene & Tropical Medicine -- the results provide strong grounds to test the effect of this treatment in a larger and definitive study. The forthcoming CRASH-3 trial will determine reliably the effectiveness of tranexamic acid in patients with head injury.

Every year millions of people world-wide are treated for head injury. Unfortunately, currently there is no proven effective treatment for this life threatening condition, which affects mainly young working people. One of the frequent complications occurring after head injury is bleeding into the head. Usually this bleeding progresses in the first hours after the injury and produces more brain damage. Because tranexamic acid reduces clot breakdown the investigators hypothesised that this drug could reduce bleeding into the brain and therefore improve patients' outcomes.

The CRASH-2 Intracranial Bleeding Study was the first to evaluate the effect of tranexamic acid on head injury patients. The results showed that patients who receive tranexamic acid were less likely to have bleeding progression, they survive more and with less disability.

Dr Pablo Perel, who is based in the Clinical Trials Unit at LSHTM, says: "Although the results are not definitive they provide hope about the potential effectiveness of this simple drug for head injury patients. If such an inexpensive and widely practicable treatment were found to improve patient outcomes after head injury this would have major implications for clinical care."

Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study) BMJ 2011;342:d3795 doi: 10.1136/bmj.d3795

The study involved 270 adult trauma patients with, or at risk of, significant extracranial bleeding within 8 hours of injury, who also had traumatic brain injury. It was a prospective randomised controlled trial carried out within the larger CRASH-2 trial to quantify the effect of an early short course of tranexamic acid on intracranial haemorrhage.

In May 2011, the CRASH-2 trial collaborators' paper: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010: doi:10.1016/S0140-6736(10)60835-5 was named Research Paper of the Year in the BMJ Group Awards.


Story Source:

The above story is based on materials provided by London School of Hygiene & Tropical Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. CRASH-2 Collaborators (Intracranial Bleeding Study). Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ, 2011; 342: d3795 DOI: 10.1136/bmj.d3795

Cite This Page:

London School of Hygiene & Tropical Medicine. "Potential of simple injection on patients with head injury." ScienceDaily. ScienceDaily, 2 July 2011. <www.sciencedaily.com/releases/2011/06/110630220011.htm>.
London School of Hygiene & Tropical Medicine. (2011, July 2). Potential of simple injection on patients with head injury. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2011/06/110630220011.htm
London School of Hygiene & Tropical Medicine. "Potential of simple injection on patients with head injury." ScienceDaily. www.sciencedaily.com/releases/2011/06/110630220011.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com
Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Newsy (Apr. 14, 2014) Richard van As lost all fingers on his right hand in a woodworking accident. Now, he's used the incident to create a prosthetic to help hundreds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins